Carnivorous Plant Ditches Its ‘Junk’ DNA
Brett Smith for redOrbit.com – Your Universe Online There are approximately 3 billion base pairs in the human genome, however, only about 2 percent of those are actual genes. The rest is considered ‘junk’ DNA. For years, scientists have...
Latest Molecular biology Stories
ALBANY, New York, May 21, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market was valued at USD 2.4 billion in 2011 and is expected to grow at a CAGR of 10.1% from 2012 to 2018, to reach...
AMSTERDAM, The Netherlands, May 21, 2013 /PRNewswire/ -- uniQure B.V., a leader in the field of human gene therapy, today announced that with its consortium partners it is to receive a EUR 2.5 million Eurostars grant to develop an RNA interference (RNAi) gene therapy for Huntington's disease. The consortium is a pan-European collaboration consisting of uniQure as the coordinator, Lausanne University Hospital, Switzerland, University Medical Center Gottingen, Germany, and...
BALTIMORE, May 21, 2013 /PRNewswire/ -- Personal Genome Diagnostics Inc. (PGDx), today announced that it will use its proprietary methodologies and expertise in genomic analysis of defined cancer subtypes to identify novel kinase targets in collaboration with Blueprint Medicines. PGDx is an innovator in conducting patient-specific analyses aimed at identifying genomic alterations in tumors, and Blueprint Medicines is an expert in developing highly selective kinase inhibitors for a...
Selexis’ co-founder and scientific advisory board member will present, “Engineering the CHO Genome for Improved Transgene Integration and Expression” Geneva, Switzerland (PRWEB) May 20, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today that the Company’s co-founder will present data on the Company’s core technology at the 2013 Cell...
SAN DIEGO, May 20, 2013 /PRNewswire/ -- Dr. Gerald Zon, noted scientist in the field of nucleic acid research, recently launched a new blog in conjunction with TriLink BioTechnologies. The blog, Zone In with Zon (zon.trilinkbiotech.com), focuses on what's trending in the field of nucleic acids. Blog posts include interviews with industry thought leaders, discussions of research presented at conferences and meetings, reviews of current publications and more. Dr. Zon (PhD Princeton...
Production of Therapeutically Relevant Levels of Clotting Factor VIII Further Demonstrates Breadth and Leverage of this Novel Approach to Monogenic Diseases RICHMOND, Calif., May 20, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new data demonstrating the successful application of Sangamo's proprietary In Vivo Protein Replacement Platform (IVPRP) to produce therapeutically relevant levels of Factor VIII in a mouse model. Sangamo has...
MetLife Foundation today announced the recipients of its 2013 Awards for Medical Research in Alzheimer’s Disease: Yueming Li, Ph.D., member and professor, Sloan-Kettering Institute and director and professor, Graduate Program in Pharmacology, Weill Medical College of Cornell University, and Lennart Mucke, M.D., director, Gladstone Institute of Neurological Disease, Joseph B. Martin Distinguished Professor of Neuroscience and professor of Neurology, University of California, San...
Bestselling sequencing system is now even more powerful: new workflow automation, Ion PGM(TM) chips and software to be deployed to all new and existing users CARLSBAD, Calif., May 14, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that Ion PGM(TM) now significantly outperforms its competitor on the major performance metrics for benchtop sequencing. It offers the simplest and fastest workflow, lowest cost-per-sample, and highest sensitivity for...
The global electrophoresis market is expected to reach nearly $1.8 billion by 2018 after increasing at a CAGR of 4%. The expanding realm of molecular profiling applications is providing continued demand for this technology, ahlthrough electrophoresis exhibits characteristics of a mature market; which nucleic acid and protein separation are the two major applications of this technology. Wellesley, MA (PRWEB) May 12, 2013 The global electrophoresis market was worth nearly $1.35 billion in...
CARLSBAD, Calif., May 13, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today the issuance of a new patent covering nucleic acids encoding Transcription Activator-Like Effector Nuclease fusion proteins (TALENS) and the formal launch of an associated sublicensing program. The technology has broad utility in the pharmaceutical industry, synthetic biology, and plant sciences for creating genetically modified cell lines, animals and plants, and is being...
Latest Molecular biology Reference Libraries
The activity of any living cell, and by extension life itself, depends on protein synthesis and the transcription of DNA. If proteins are the machinery of cellular function, then DNA are the machine assembly lines – responsible for accurately and efficiently ‘transcribing’ protein messengers, structures and enzymes. DNA transcription begins in the nucleus of a cell when an enzyme called RNA polymerase binds to the DNA strand. Sequences within the DNA direct the polymerase to...
According to the Bureau of Labor Statistics, a highly technical field like genetic engineering can be a beacon of stability and growth in today’s slumping job market. Genetic engineers, or biomedical engineers, are expected to see their career prospects grow as new technological advances drive an ever greater demand for individuals to specialize in this field. The National Human Genome Research Institute (NHGRI) says that a position as a genetic engineer typically requires at least a...
Cell is a peer-reviewed scientific journal founded by Benjamin Lewin in January 1974 with the sponsorship of MIT Press. Lewin bought the rights to the journal in 1986 and published it under his own publishing arm Cell Press. Cell Press was sold to Elsevier in 1999, which currently publishes Cell twice monthly. Cell Press publishes several biomedical journals, including Cell, Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry &...
